The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 30, 2024

Filed:

Nov. 16, 2022
Applicants:

Wuhan Academy of Agricultural Sciences, Wuhan, CN;

Hubei Wudang Animal Pharmaceutical Co., Ltd., Chengguan Town, CN;

Inventors:

Bin He, Wuhan, CN;

Lijun Wu, Wuhan, CN;

Zheng Lu, Wuhan, CN;

Zhiping Ran, Wuhan, CN;

Guoming Chen, Wuhan, CN;

Zhiyong Shao, Wuhan, CN;

Xiabing Chen, Wuhan, CN;

Wei Liu, Wuhan, CN;

Ying Li, Wuhan, CN;

Wu Liu, Wuhan, CN;

Qi Zhou, Wuhan, CN;

Wenhai Yang, Wuhan, CN;

Dongqing Liu, Wuhan, CN;

Kangyu Du, Wuhan, CN;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/365 (2006.01); A61K 9/107 (2006.01); A61K 9/14 (2006.01); A61K 36/23 (2006.01); A61K 36/54 (2006.01); A61K 47/10 (2017.01); A61K 47/44 (2017.01);
U.S. Cl.
CPC ...
A61K 31/365 (2013.01); A61K 9/107 (2013.01); A61K 9/14 (2013.01); A61K 36/23 (2013.01); A61K 36/54 (2013.01); A61K 47/10 (2013.01); A61K 47/44 (2013.01);
Abstract

The present disclosure provides an arctigenin liquid nano-preparation and a preparation method thereof, and relates to the technical field of pharmaceutical preparation. In the present disclosure, arctigenin is prepared into a liquid nano-preparation, having advantages of distribution of a droplet diameter on nanoscale, significantly increased specific surface area, rapid absorption, and high bioavailability. Meanwhile, nano-preparation entered the body can be captured by wandering leucocytes, and a medicament is delivered to inflammatory lesions through chemiotaxis, thereby conferring a targeted drug delivery feature on the arctigenin and making a therapy more targeted.


Find Patent Forward Citations

Loading…